1. Oishi, Mayumi, Shinjo, Keiko, Takanari, Keisuke, Kamei, Yuzuru, Kondo, Yutaka. 2024. Exclusive expression of KANK4 promotes myofibroblast mobility in keloid tissues. In Scientific reports, 14, 8725. doi:10.1038/s41598-024-59293-z. https://pubmed.ncbi.nlm.nih.gov/38622256/
2. Jabeen, Almas, Ahmad, Nadeem, Raza, Khalid. 2022. Global Gene Expression and Docking Profiling of COVID-19 Infection. In Frontiers in genetics, 13, 870836. doi:10.3389/fgene.2022.870836. https://pubmed.ncbi.nlm.nih.gov/35480316/
3. Gaule, Marina, Pesoni, Camilla, Quinzii, Alberto, Vellani, Giorgio, Melisi, Davide. . Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion. In JCO precision oncology, 6, e2100400. doi:10.1200/PO.21.00400. https://pubmed.ncbi.nlm.nih.gov/35005993/
4. Gee, Heon Yung, Zhang, Fujian, Ashraf, Shazia, Han, Zhe, Hildebrandt, Friedhelm. 2015. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. In The Journal of clinical investigation, 125, 2375-84. doi:10.1172/JCI79504. https://pubmed.ncbi.nlm.nih.gov/25961457/
5. Anjanappa, Ram M, Nayak, Sourav, Moily, Nagaraj S, Jain, Sanjeev, Anand, Anuranjan. 2019. A linkage and exome study implicates rare variants of KANK4 and CAP2 in bipolar disorder in a multiplex family. In Bipolar disorders, 22, 70-78. doi:10.1111/bdi.12815. https://pubmed.ncbi.nlm.nih.gov/31400178/
6. Hendrickx, Debbie A E, van Scheppingen, Jackelien, van der Poel, Marlijn, Hamann, Jörg, Huitinga, Inge. 2017. Gene Expression Profiling of Multiple Sclerosis Pathology Identifies Early Patterns of Demyelination Surrounding Chronic Active Lesions. In Frontiers in immunology, 8, 1810. doi:10.3389/fimmu.2017.01810. https://pubmed.ncbi.nlm.nih.gov/29312322/
7. Rao, Bhavna S, Ansar, Samdani, Arokiasamy, Tharigopala, Rajagopal, Rama, Soumittra, Nagasamy. 2018. Analysis of candidate genes ZEB1 and LOXHD1 in late-onset Fuchs' endothelial corneal dystrophy in an Indian cohort. In Ophthalmic genetics, 39, 443-449. doi:10.1080/13816810.2018.1474367. https://pubmed.ncbi.nlm.nih.gov/29799290/
8. Xiao, Zicheng, Cai, Zhiyong, Deng, Dingshan, Tong, Shiyu, Zu, Xiongbing. 2022. An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer. In Frontiers in immunology, 13, 1000321. doi:10.3389/fimmu.2022.1000321. https://pubmed.ncbi.nlm.nih.gov/36211349/